TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | -1 | 9 | -14 | -40 | -35 | -71 | -25 |
| P | %wins | 50 | 50 | 0 | 0 | 0 | 0 | 17 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/25/11 21:09 | 7/21/11 | NGSX | Neurogesx Inc | CA | Health | Drug | Pharmaceutical Preparations | Arch Venture Fund V LP | IL | T | P.d | 2,878 | 1.65 | 0 | 1,744 | 71 | 4,188 | D | -79 | -76 | -72 | -49 | -5 | -2 | -4 | 1 | 0 | 38 | -3 | -46 | -49 | ||
11/1/10 16:18 | 10/28/10 | TRBN | Trubion Pharmaceuticals, Inc | DE | Health | Drug | Pharmaceutical Preparations | Arch Venture Fund V LP | IL | T | S | 0 | 0.00 | 0 | -2,357 | -100 | 0 | D | |||||||||||||||
5/4/07 17:04 | 5/2/07 | NGSX | Neurogesx Inc | CA | Health | Drug | Pharmaceutical Preparations | Arch Venture Fund V LP | IL | T | P | 2,497 | 11.00 | 9 | 227 | New | 227 | D | -1 | -20 | -25 | -33 | -20 | -71 | |||||||||
10/19/06 15:04 | 10/17/06 | TRBN | Trubion Pharmaceuticals, Inc | Health | Drug | Pharmaceutical Preparations | Arch Venture Fund V LP | IL | T | P | 580 | 13.00 | 0 | 45 | 188 | 68 | D | ||||||||||||||||
3/22/04 21:32 | 3/19/04 | XCYT | Xcyte Therapies Inc | WA | Health | Drug | Pharmaceutical Preparations | Arch Venture Fund V LP | IL | T | P.d | 1,500 | 8.00 | 0 | 188 | 10 | 2,054 | M |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |